Ariana Pharma

Seek Fast-Track Drug Development

SHARE

Using our pioneering eXplainable AI platform KEM® we design and execute Precision Medicine clinical trials, with an unparalleled successful track record across multiple therapeutic areas. Thanks to our XAI KEM® platform we integrate extensive pre-clinical, clinical as well as Real World Evidence data, to define best dose, identify patient selection and surrogate endpoint biomarkers as well as alternative clinical indications. Our Precision Medicine clinical protocols allow for extensive data collection and use of stratification biomarkers, enabling accelerated approval regulatory pathways.

Most popular related searches

Our technology matches all steps of clinical development and can be used even with small datasets of 10-20 patients.

  • PROVEN TRACK RECORD: + 20 years in AI and drug development
  • BROAD THERAPEUTIC DOMAINS